BIOCAPX is a technology-driven investment platform designed to be an innovative and transformative way to finance drug development. We provide the infrastructure needed to directly invest in single assets and indications under development.
| Website | http://biocapx.com |
| Revenue | $2 million |
| Employees | View employees |
| Founded | 2016 |
| Technologies |
JavaScript
,
HTML
,
Twitter
+9 more
(view full list)
|
| Industry | Biotechnology Research, Manufacturing General, Clinical Trials, Manufacturing, Health Care, Financial Services, Marketplace, Commerce and Shopping |
| Keywords | Biotech Investments, Pharmaceutical Funding, Biotechnology Venture Capital, Life Sciences Investing, Pharmaceutical Investment, Healthcare Venture Capital, Early Stage Biotech, Medical Technology Investment, Asset Based Financing, Healthcare Investment, Investment Platform |
| Competitors | Thermo Fisher Scientific, Bayer, AstraZeneca, Amgen, Corteva Agriscience, Novozymes, CureVac, Geno, APPLIED BIOPROBES, LLC +27 more (view full list) |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 3254 Companies, NAICS Code 32 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies |
Looking for a particular BIOCAPX employee's phone or email?
BIOCAPX Questions
The BIOCAPX annual revenue was $2 million in 2026.
The NAICS codes for BIOCAPX are [3254, 32, 32541, 325].
The SIC codes for BIOCAPX are [28, 283].
Related Companies
G2Crowd Trusted
300K+
Plugin Users
